|
|
Office Locations:
|
570 Lexington Ave., 15th Floor
New York, NY 10022
Phone: 212-371-7900
Fax: 212-371-2150
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
|
Nazem and Company, established in 1976, is an alternative asset management investment firm. As both venture investors and money managers, Nazem and Company's aim is to create enduring assets and generate superior returns for its partners, while producing a stream of innovative products and services for new growth industries. The firm invests in all stages of enterprise development, from seed stage to follow-on financings to late-stage pre-IPO financings. It also invests in stress and turnaround situations where the firm can lead the reorganization efforts. The firm focuses primarily on companies in the healthcare and technology sectors. Transatlantic Venture Partners is a venture capital fund organized in the Netherlands Antilles in 1995 and is co-managed by Nazem and Company and BNP Paribas (formerly Banque Nationale de Paris). Over the last 35 years, Nazem and Company has shepherded some 300 companies, taken more than 50 public, and some two dozen of them have achieved revenues and market values in excess of $1 billion.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
